What is the next indicated intervention for a stable 16‑year‑old female presenting with acute nausea, vomiting, mild generalized abdominal pain, benign abdominal examination, normal laboratory studies, and a history of frequent hot showers?

Cannabis Hyperemesis Syndrome: Topical Capsaicin is the Next Indicated Intervention

In a stable 16-year-old with nausea, vomiting, generalized abdominal pain, benign examination, normal labs, and frequent hot showers, topical capsaicin is the next indicated intervention because this presentation is pathognomonic for Cannabis Hyperemesis Syndrome (CHS), and capsaicin directly addresses the underlying TRPV1 receptor dysfunction that drives both the compulsive hot-water bathing and the vomiting. 1

Why This Clinical Picture Screams Cannabis Hyperemesis Syndrome

• The history of taking multiple hot showers daily is virtually diagnostic of CHS, as this compulsive hot-water bathing behavior is the single most specific clinical feature distinguishing CHS from other causes of cyclic vomiting 1
• Cannabis use is extremely common in this age group, and a urine drug screen should be obtained to confirm cannabinoid exposure, though treatment should not be delayed while awaiting results 1
• The benign abdominal exam and unremarkable labs effectively exclude acute surgical abdomen, metabolic derangements, and inflammatory processes that would require different management 1

Why the Other Options Are Wrong for This Patient

Intravenous Ondansetron (Incorrect)

• Ondansetron is ineffective for CHS because the pathophysiology involves TRPV1 receptor dysfunction in the hypothalamus and gastrointestinal tract, not serotonergic pathways 1
• While ondansetron is first-line for chemotherapy-induced or postoperative nausea 2, it does not address the specific receptor abnormality in CHS 1
• The patient is stable with normal vital signs, making immediate antiemetic administration less urgent than definitive treatment of the underlying syndrome 1

CT Abdomen with Contrast (Incorrect)

• Imaging is not indicated when the abdominal exam is benign and labs are normal, as this represents low-risk undifferentiated nausea and vomiting 1
• The guideline explicitly recommends one-time upper GI imaging or EGD to exclude obstructive lesions, but discourages repeated imaging 1
• In a stable patient with a classic CHS presentation, CT would expose the patient to unnecessary radiation and delay definitive therapy 1

Intravenous Fluid Bolus (Incorrect)

• While IV fluids are indicated for severe dehydration, shock, altered mental status, or failure of oral rehydration 1, this patient has stable vital signs
• Oral rehydration solution (ORS) is first-line therapy for mild-to-moderate dehydration in all age groups, even when vomiting is present 1
• IV fluids do not treat the underlying TRPV1 dysfunction and would only provide temporary symptomatic relief 1

How Topical Capsaicin Works in CHS

• Capsaicin is a TRPV1 receptor agonist that mimics the mechanism by which hot showers provide relief—by activating the same receptors that are dysregulated by chronic cannabis use 1
• Patients with CHS compulsively seek hot water because it temporarily activates cutaneous TRPV1 receptors, providing transient symptom relief 1
• Topical capsaicin cream applied to the abdomen provides sustained TRPV1 activation without requiring the patient to remain in a hot shower 1

Practical Management Algorithm

Immediate Actions (First 30 Minutes)

• Apply topical capsaicin 0.025–0.1% cream to the abdomen in a generous layer, which can be repeated every 4–6 hours as needed 1
• Obtain urine drug screen to document cannabinoid use, though a negative screen does not exclude CHS if the clinical picture is classic 1
• Offer oral rehydration solution (50–100 mL/kg over 3–4 hours for adolescents) to address any mild dehydration 1

If Symptoms Persist After Capsaicin (1–2 Hours)

• Add a dopamine-receptor antagonist such as metoclopramide 10 mg IV/PO or prochlorperazine 10 mg IV/PO, as these are first-line antiemetics for persistent vomiting 1, 3
• Consider adding ondansetron 4–8 mg IV/PO only if dopamine antagonists are insufficient after 4 weeks of symptoms, as it targets different receptors 1
• Do not use ondansetron as monotherapy in suspected CHS, as it will likely fail 1

Critical Counseling Points

• Definitive diagnosis requires 6 months of cannabis cessation or at least 3 typical cycle lengths without vomiting 1
• Do not stigmatize the patient—offer abortive and prophylactic therapy even with ongoing cannabis use, as treatments can still be effective 1
• Explain that continued cannabis use will perpetuate the syndrome and that cessation is the only curative intervention 1

Common Pitfalls to Avoid

• Never dismiss the hot-shower history as coincidental—it is the key diagnostic clue that separates CHS from viral gastroenteritis, cyclic vomiting syndrome, or other causes 1
• Avoid repeated endoscopy or imaging unless new symptoms develop, as this exposes the patient to unnecessary procedures 1
• Do not delay capsaicin application while waiting for antiemetic trials to fail, as capsaicin directly addresses the pathophysiology 1
• Monitor for extrapyramidal symptoms if dopamine antagonists are added, particularly in young patients 1